Brief: Q BioMed Inc Says ITG Is Now Cleared To Manufacture Co's FDA Approved Non-Opioid Cancer Bone Pain Drug Strontium-89 Chloride USP
20/11/2019 13:59
Nov 20 (Reuters) - Q BioMed Inc QBIO.PK :
* Q BIOMED ANNOUNCES FDA APPROVAL
* Q BIOMED INC - ITG IS NOW CLEARED TO MANUFACTURE COMPANY'S
FDA
APPROVED NON-OPIOID CANCER BONE PAIN DRUG STRONTIUM-89 CHLORIDE
USP
Source text for Eikon: ID:nPn6NlFzSa
Further company coverage: QBIO.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q BioMed
See all newsBrief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
Brief: Q Biomed Provides Shareholder Update
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
Brief: Q Biomed To Scale Up Production Of Uttroside-B